ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
NCT06922539 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2025-12-15
Summary
This study evaluates a fenretinide phospholipid suspension for the treatment of small cell lung cancer (SCLC).
Conditions
Interventions
- DRUG
-
Fenretinide
Intravenous administration
- DRUG
-
Fenretinide
Intravenous administration
Sponsors & Collaborators
-
SciTech Development, Inc.
lead INDUSTRY
Principal Investigators
-
Ali Moiin, MD · SciTech Development, Inc.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-11
- Primary Completion
- 2027-05-01
- Completion
- 2028-10-01
- FDA Drug
- Yes
Countries
- United States
More Related Trials
-
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
NCT00387504 ·Status: COMPLETED ·Phase: PHASE1
-
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
NCT00662636 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841
NCT06219499 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
NCT00682279 ·Status: WITHDRAWN ·Phase: PHASE1
-
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
NCT00019656 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors
NCT00628732 ·Status: COMPLETED ·Phase: PHASE2
-
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
NCT00969306 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
NCT02645175 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
NCT05019716 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies
NCT00295243 ·Status: COMPLETED ·Phase: PHASE1
-
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00004176 ·Status: COMPLETED ·Phase: PHASE2
-
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer
NCT01628471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer
NCT01575782 ·Status: TERMINATED ·Phase: PHASE1
-
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer
NCT00059943 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
NCT01317550 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
NCT00002587 ·Status: COMPLETED ·Phase: PHASE1
-
Study of 124I-NM404 in Advanced Solid Malignancies
NCT01662284 ·Status: TERMINATED
-
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
NCT00382733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor
NCT04122118 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
NCT03459729 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
NCT00003583 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
NCT03864042 ·Status: COMPLETED ·Phase: PHASE1
-
Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00003242 ·Status: COMPLETED ·Phase: PHASE1
-
Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
NCT00193570 ·Status: COMPLETED ·Phase: PHASE1